• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Portable Diagnostic Devices Companies

    ID: MRFR/HC/5752-CR
    128 Pages
    Kinjoll Dey
    September 2023

    Portable diagnostic devices play a critical role in healthcare by providing medical professionals with convenient and rapid means to diagnose, monitor, and manage patients' health conditions. These devices are often compact, user-friendly, and capable of delivering quick results.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Portable Diagnostic Devices Market Research Report—Global Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Portable Diagnostic Devices Market

    Portable Diagnostic Devices Key Companies*Disclaimer: List of key companies in no particular orderLatest Portable diagnostic devices Companies Update



    • Oct 2023: A joint venture and licensing agreement has been announced by Roche and Monte Rosa Therapeutics to develop and discover molecular glue degraders (MGDs) to treat neurological and cancerous illnesses. The collaboration aims to bring together Roche's experience in patient treatment and Monte Rosa's QuEENT discovery engine. The upfront payment to Monte Rosa is $50 million. Based on preclinical, clinical, commercial, and sales milestones, the company may receive future payments surpassing $2 billion in addition to tiered royalties. The parties also expanded their cooperation in the initial two years to include more targets. Instead of tiered royalties on the resulting drugs, further payments will be given for nominations and reaching preclinical, clinical, commercial, and sales milestones. Monte Rosa will oversee preclinical and discovery research against certain cancer and neurological disorders.




    • Aug 2023: A new partnership to address health disparities and lower the risk of heart attacks and strokes in underprivileged Detroit communities was announced today by OMRON Healthcare, a pioneer in global heart health, and EPIC Health, Detroit's healthcare system dedicated to community-focused healthcare. Program participants will have access to VitalSightTM, OMRON's inaugural remote patient monitoring service created exclusively for people with uncontrolled Stage 2 hypertension and other high blood pressure patients. Physicians can provide individuals with elevated hypertension levels with an easy-to-use remote monitoring program called VitalSight. Uncontrolled Stage 2 hypertension affects around 37 million adults in the United States1. If therapy is not received, this condition could raise the danger of heart attacks and strokes, which could cause damage to the arteries and other organs.


    List of Portable diagnostic devices Key companies in the market

    • Hoffmann-La Roche Ltd

    • GE Healthcare

    • Medtronic

    • Omron Healthcare Inc.

    • Koninklijke Philips N.V.

    • Abbott

    • COM

    • Stryker

    • Wellue

    • EMAY